Books > Medicine > Clinical & internal medicine
|
Buy Now
Statistical Thinking for Non-Statisticians in Drug Regulation, 3rd Edition (Hardcover, 3rd Edition)
Loot Price: R1,915
Discovery Miles 19 150
|
|
Statistical Thinking for Non-Statisticians in Drug Regulation, 3rd Edition (Hardcover, 3rd Edition)
Expected to ship within 12 - 17 working days
|
STATISTICAL THINKING FOR NON-STATISTICIANS IN DRUG REGULATION
Statistical methods in the pharmaceutical industry are accepted as
a key element in the design and analysis of clinical studies.
Increasingly, the medical and scientific community are aligning
with the regulatory authorities and recognizing that correct
statistical methodology is essential as the basis for valid
conclusions. In order for those correct and robust methods to be
successfully employed there needs to be effective communication
across disciplines at all stages of the planning, conducting,
analyzing and reporting of clinical studies associated with the
development and evaluation of new drugs and devices. Statistical
Thinking for Non-Statisticians in Drug Regulation provides a
comprehensive in-depth guide to statistical methodology for
pharmaceutical industry professionals, including physicians,
investigators, medical science liaisons, clinical research
scientists, medical writers, regulatory personnel, statistical
programmers, senior data managers and those working in
pharmacovigilance. The author's years of experience and up-to-date
familiarity with pharmaceutical regulations and statistical
practice within the wider clinical community make this an essential
guide for the those working in and with the industry. The third
edition of Statistical Thinking for Non-Statisticians in Drug
Regulation includes: A detailed new chapter on Estimands in line
with the 2019 Addendum to ICH E9 Major new sections on topics
including Combining Hierarchical Testing and Alpha Adjustment,
Biosimilars, Restricted Mean Survival Time, Composite Endpoints and
Cumulative Incidence Functions, Adjusting for Cross-Over in
Oncology, Inverse Propensity Score Weighting, and Network
Meta-Analysis Updated coverage of many existing topics to reflect
new and revised guidance from regulatory authorities and author
experience Statistical Thinking for Non-Statisticians in Drug
Regulation is a valuable guide for pharmaceutical and medical
device industry professionals, as well as statisticians joining the
pharmaceutical industry and students and teachers of drug
development.
General
Imprint: |
Wiley-Blackwell
|
Country of origin: |
United States |
Release date: |
December 2022 |
Authors: |
R. Kay
|
Dimensions: |
245 x 177 x 29mm (L x W x T) |
Format: |
Hardcover
|
Pages: |
432 |
Edition: |
3rd Edition |
ISBN-13: |
978-1-119-86738-8 |
Categories: |
Books >
Medicine >
Clinical & internal medicine >
General
|
LSN: |
1-119-86738-X |
Barcode: |
9781119867388 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.